Literature DB >> 29222041

TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma.

Woo-Kyun Bae1, Chang-Soo Hong1, Mi-Ra Park1, Eun-Gene Sun1, Ji-Hee Lee1, Keunsoo Kang2, Kyung-Hyun Ryu3, Hyun-Jeong Shim1, Jun-Eul Hwang1, Sang-Hee Cho1, Ik-Joo Chung4.   

Abstract

p73 is a member of the p53 family of transcription factors and, like p53, plays a role as a tumor suppressor. p73 is involved in development, proliferation, apoptosis and metastasis. However, the precise molecular mechanisms underlying its function in inhibiting metastasis remain largely unknown. Here, we show that induction of TAp73 decreased invasion and migration activity of colorectal cancer cells, whereas knockdown of TAp73 led to increased invasion and migration activity. KAI1 was identified as a transcriptional target of TAp73 and its expression is indispensable for TAp73-mediated inhibition of cell invasion and migration. Furthermore, induction of TAp73 in colorectal cancer cells elevated KAI1 expression and decreased the frequency of hepatic metastasis in vivo. Whereas, the decreased invasion and migration activities caused by TAp73 induction were abrogated by knockdown of KAI1. Interestingly, TAp73 and KAI1 are overexpressed in primary colorectal cancers and a significant correlation between TAp73 and KAI1 expression was detected, but their expressions were significantly down-regulated in metastatic cancers. Taken together, our results support a novel role for TAp73 in controlling colorectal cancer cell invasion, migration and metastasis by regulating transcription of KAI1.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Invasion; KAI1; Migration; p73

Mesh:

Substances:

Year:  2017        PMID: 29222041     DOI: 10.1016/j.canlet.2017.12.002

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  A Novel Expression Profile of Cell Cycle and DNA Repair Proteins in Nonfunctioning Pituitary Adenomas.

Authors:  Derya Metin-Armagan; Nil Comunoglu; Gulay Bulut; Pinar Kadioglu; Hiraku Kameda; Nurperi Gazioglu; Necmettin Tanriover; Melek Ozturk
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

2.  Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1.

Authors:  Chang-Soo Hong; Mi-Ra Park; Eun-Gene Sun; Wonyoung Choi; Jun-Eul Hwang; Woo-Kyun Bae; Joon Haeng Rhee; Sang-Hee Cho; Ik-Joo Chung
Journal:  Front Immunol       Date:  2019-07-26       Impact factor: 7.561

Review 3.  p53-Related Transcription Targets of TAp73 in Cancer Cells-Bona Fide or Distorted Reality?

Authors:  Chao Wang; Cui Rong Teo; Kanaga Sabapathy
Journal:  Int J Mol Sci       Date:  2020-02-17       Impact factor: 5.923

4.  Genomic and transcriptomic characterization of the human glioblastoma cell line AHOL1.

Authors:  W A S Ferreira; C K N Amorim; R R Burbano; R A R Villacis; F A Marchi; T S Medina; M M C de Lima; E H C de Oliveira
Journal:  Braz J Med Biol Res       Date:  2021-01-15       Impact factor: 2.590

Review 5.  KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers.

Authors:  Shuo Wang; Jiang Chen; Xiao-Zhong Guo
Journal:  World J Gastrointest Oncol       Date:  2022-08-15

6.  Hsa-miR-217 Inhibits the Proliferation, Migration, and Invasion in Non-small Cell Lung Cancer Cells Via Targeting SIRT1 and P53/KAI1 Signaling

Authors:  Wenxia Jiang; Likun Hou; Juan Wei; Yifeng Du; Yan Zhao; Xue Deng; Xiangdong Lin
Journal:  Balkan Med J       Date:  2020-04-09       Impact factor: 2.021

7.  p73 Is Required for Ovarian Follicle Development and Regulates a Gene Network Involved in Cell-to-Cell Adhesion.

Authors:  Gabriela L Santos Guasch; J Scott Beeler; Clayton B Marshall; Timothy M Shaver; Quanhu Sheng; Kimberly N Johnson; Kelli L Boyd; Bryan J Venters; Rebecca S Cook; Jennifer A Pietenpol
Journal:  iScience       Date:  2018-09-25

Review 8.  Dual Role of p73 in Cancer Microenvironment and DNA Damage Response.

Authors:  Julian M Rozenberg; Svetlana Zvereva; Alexandra Dalina; Igor Blatov; Ilya Zubarev; Daniil Luppov; Alexander Bessmertnyi; Alexander Romanishin; Lamak Alsoulaiman; Vadim Kumeiko; Alexander Kagansky; Gerry Melino; Nikolai A Barlev
Journal:  Cells       Date:  2021-12-13       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.